Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1992-07-28
1994-11-15
Phelan, D. Gabrielle
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424462, 424457, 424458, 424459, 424468, 424490, A61K 916
Patent
active
053646207
ABSTRACT:
A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid, and a multi-layer membrane surrounding the core and containing a major proportion of a pharmaceutically acceptable film-forming, water insoluble synthetic polymer and a minor proportion of a pharmaceutically acceptable film-forming, water soluble synthetic polymer. The number of layers in the membrane and the ratio of the water soluble to water insoluble polymer being effective to permit release of the diltiazem from the pellet at a rate allowing controlled absorption thereof over a twenty four hour period following oral administration.
REFERENCES:
patent: 2853420 (1958-09-01), Lowey
patent: 4443497 (1984-04-01), Samejima
patent: 4459279 (1984-07-01), Stricker
patent: 4462982 (1984-07-01), Samejima
patent: 4555398 (1985-11-01), Oda
patent: 4587242 (1986-05-01), Manghisi
patent: 4608248 (1986-08-01), Knecht
patent: 4721619 (1988-01-01), Panoz et al.
patent: 4786503 (1988-11-01), Edgren
patent: 4792452 (1988-12-01), Howard
patent: 4795642 (1989-01-01), Cohen
patent: 4795644 (1989-01-01), Zentner
patent: 4814183 (1989-03-01), Zentner
patent: 4894240 (1990-01-01), Geoghegan et al.
Modern Pharmaceutics (1979) (vol. 6, pp. 138-161)-"Sustained and Controlled Release Drug Delivery Systems", edited by Joseph R. Robinson.
Am. J. of Cardiology 49:530-532-"The Pharmacokinetics of Diltiazem in Healthy American Men", Robert F. Zelis, MD, FACC, Evlin L. Kinney, MD.
Geoghegan Edward J.
Mulligan Seamus
Panoz Donald E.
Church Marla J.
Elan Corporation, plc
Phelan D. Gabrielle
LandOfFree
Controlled absorption diltiazem formulation for once daily admin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled absorption diltiazem formulation for once daily admin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled absorption diltiazem formulation for once daily admin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1095648